InMode Ltd.

INMD Healthcare Medical Devices

InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.

14.16 0.16 −1.12%
Market cap
$824.0M
P/E
11.3×
Fwd P/E
11.8×
Dividend yield
—
F-score
4/9
Altman Z
10.45
Beneish M
−2.25
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
53.46 100.16 156.36 206.11 357.57 454.27 492.05 394.82 370.50
Revenue Growth
(46.63%) 87.37% 56.11% 31.81% 73.49% 27.05% 8.32% (19.76%) (6.16%)
Cost of Revenue
9.05 15.06 20.24 30.85 53.59 73.49 80.71 77.75 79.53
Gross Profit
44.40 85.11 136.12 175.26 303.97 380.79 411.34 317.07 290.97
R&D Expenses
2.58 4.18 5.70 9.47 9.53 12.43 13.41 13.14 13.32
SG&A Expenses
32.88 49.44 70.81 92.95 127.76 170.51 202.27 191.40 192.26
Operating Income
8.95 23.49 59.62 72.84 167.48 197.85 195.66 112.53 85.39
Non-operating Income/Expense
0.85 0.14 2.42 3.29 0.53 3.61 21.61 30.94 24.94
EBT
9.80 23.63 62.04 76.13 168.00 201.47 217.27 143.47 110.33
Income Tax Provision
0.98 1.26 0.88 1.11 2.93 39.95 19.35 (37.81) 16.50
Income after Tax
8.82 22.37 61.16 75.03 165.07 161.52 197.92 181.28 93.83
Dividends (Preferred)
— — — — 0.00 — — — —
Non-Controlling Interest
— (0.01) 0.01 0.00 0.10 — — — —
Net Income Common
8.82 22.37 61.15 75.03 164.97 161.52 197.92 181.28 93.83
EPS (Basic)
0.17 0.42 1.05 1.04 2.03 1.96 2.37 2.29 1.45
EPS (Diluted)
0.15 0.32 0.80 0.89 1.92 1.89 2.30 2.25 1.43
Shares (Basic, Weighted)
52.57 53.23 58.46 72.11 81.45 82.48 83.53 79.31 64.63
Shares (Diluted, Weighted)
59.34 70.01 76.12 84.18 86.02 85.40 85.95 80.60 65.45
Gross Margin
83.06% 84.97% 87.06% 85.03% 85.01% 83.82% 83.60% 80.31% 78.54%
EBIT Margin
16.74% 23.45% 38.13% 35.34% 46.84% 43.55% 39.76% 28.50% 23.05%
EBT margin
18.33% 23.59% 39.68% 36.94% 46.99% 44.35% 44.16% 36.34% 29.78%
Net Profit Margin
16.50% 22.33% 39.11% 36.40% 46.14% 35.56% 40.22% 45.91% 25.33%
Free Cash Flow Margin
26.98% 36.45% 39.34% 38.21% 48.65% 39.62% 35.79% 33.43% 22.75%
EBITDA
9.15 23.67 59.92 73.26 167.99 198.53 196.28 113.26 86.08
EBIT
8.95 23.49 59.62 72.84 167.48 197.85 195.66 112.53 85.39
Income from Continuous Operations
8.82 22.37 61.16 75.03 165.07 161.52 197.92 181.28 93.83
Consolidated Net Income/Loss
8.82 22.37 61.16 75.03 165.07 161.52 197.92 181.28 93.83
EPS (Basic, from Continuous Ops)
0.17 0.42 1.05 1.04 2.03 1.96 2.37 2.29 1.45
EPS (Basic, Consolidated)
0.17 0.42 1.05 1.04 2.03 1.96 2.37 2.29 1.45
EPS (Diluted, from Cont. Ops)
0.15 0.32 0.80 0.89 1.92 1.89 2.30 2.25 1.43
Shares (Diluted, Average)
— — 76.12 84.18 86.02 85.40 85.95 80.60 65.45
EPS (Diluted, Consolidated)
0.15 0.32 0.80 0.89 1.92 1.89 2.30 2.25 1.43
EBITDA Margin
17.12% 23.63% 38.32% 35.54% 46.98% 43.70% 39.89% 28.69% 23.23%
Operating Cash Flow Margin
27.33% 36.83% 39.78% 38.44% 48.91% 39.97% 35.94% 33.60% 23.01%

Fold the line items

In millions of $ except per-share values · columns are period end dates